Combined systemic and topical treatment of trichomoniasis vaginalis with azanidazol.
The Authors report the results obtained using Azanidazol on a group of 55 patients affected by Trichomoniasis and studied in the Colposcopic Section of the Obstetric and Gynecological Clinic of the University of Florence. The study was carried out on two groups of patients using two different treatment methods. Complete recovery was reported in 93.4% of the cases in the first group and 100% of those in the second group. Tolerance of the preparation was very high.
D000284:Administration, Oral; D000287:Administration, Topical; D000994:Antitrichomonal Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D009593:Nitroimidazoles / Q000008:administration & dosage*; D014245:Trichomonas Infections / Q000188:drug therapy*; D014623:Vaginal Diseases / Q000188:drug therapy*
D000994:Antitrichomonal Agents; D009593:Nitroimidazoles; C023624:azanidazole